Litigation Intel
Bard PowerPort Catheter
Implanted Bard PowerPort catheters are alleged to fracture and migrate, causing infection, blood clots and emergency surgery.
Federal MDL proceedings continue through discovery and bellwether selections, supported by consistent case filings and active nationwide plaintiff digital intake campaigns.
Score breakdown
Four dimensions, each 0-100, generated by AI from the recent signal feed plus general knowledge of the tort.
Centralized MDL proceedings continue steady case additions and pretrial discovery, maintaining active docket growth and judicial management.
Claims rest on material degradation studies and adverse event reports linking high barium sulfate concentration to polyurethane catheter fractures.
Plaintiff marketing remains prominent across digital channels, targeting individuals experiencing catheter fracture, infection, or vascular damage.
The litigation sits in the core discovery and bellwether preparation phase within federal multidistrict litigation.
Scores are generated by AI from public sources for market research. They are not legal advice or a prediction of any outcome.
Buying cases in this litigation?
We can launch an exclusive campaign to your intake criteria within one week.
Signal feed
3 recent signals across news, FDA, PubMed, and court sources.
- 📰 news·Consumer Notice·Bard PowerPort Lawsuits: What Chemo Port Patients Need to Know
- 📰 news·Lawsuit Information Center·Bard PowerPort Lawsuit | Sept 2026 Catheter Litigation Update
- 📰 news·AboutLawsuits.com·Bard PowerPort Lawsuit - Port Catheter Lawsuits - September 2026
